In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains.

The in vitro activities of three newly developed quinolone drugs (T-3262, NY-198, and fleroxacin [AM-833; RO 23-6240]) against 10 strains of clinically isolated Chlamydia trachomatis were assessed and compared with those of other quinolones and minocycline. T-3262 (MIC for 90% of isolates tested, 0....

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Maeda, H, Fujii, A, Nakata, K, Arakawa, S, Kamidono, S
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 1988
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC172348/
https://ncbi.nlm.nih.gov/pubmed/2847640
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items